Metformin and/or Clomiphene Do Not Adversely Affect Liver or Renal Function in Women with Polycystic Ovary Syndrome

CONTEXT: Nonalcoholic fatty liver disease is common to insulin-resistant states such as polycystic ovary syndrome (PCOS). Metformin (MET) is often used to treat PCOS but information is limited as to its effects on liver function. OBJECTIVE: We sought to determine the effects of MET on serum hepatic...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Aubuchon, Mira, Kunselman, Allen R., Schlaff, William D., Diamond, Michael P., Coutifaris, Christos, Carson, Sandra A., Steinkampf, Michael P., Carr, Bruce R., McGovern, Peter G., Cataldo, Nicholas A., Gosman, Gabriella G., Nestler, John E., Myers, Evan R., Legro, Richard S.
Formato: Artigo
Idioma:Inglês
Publicado: Endocrine Society 2011
Assuntos:
JCEM Online: Brief Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3200244/
https://ncbi.nlm.nih.gov/pubmed/21832111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2011-1093
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares